Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Inoue

Showing results (311-320 of 387) with videos related to

Pageof 39
Sort By:
The Lancet. Oncology|May 4, 2013
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 studyTakashi Seto, Katsuyuki Kiura, Makoto Nishio, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2015
Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutationTatsuro Fukuhara, Makoto Maemondo, Akira Inoue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Shunichi Sugawara, Koichi Yamazaki, et al.
Clinical Lung Cancer|June 5, 2018
A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study ProtocolYoshihito Kogure, Hideo Saka, Yuichi Takiguchi, et al.
International Surgery|July 25, 2014
Short-term outcomes of simultaneous laparoscopic colectomy and hepatectomy for primary colorectal cancer with synchronous liver metastasesAkira Inoue, Mamoru Uemura, Hirofumi Yamamoto, et al.
Respiratory Investigation|May 24, 2014
Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802Yosuke Kawashima, Akira Inoue, Shunichi Sugawara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisChee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Akira Inoue, Shunichi Sugawara, et al.
International Journal of Cancer|July 18, 2009
Frequency of and variables associated with the EGFR mutation and its subtypesTomoaki Tanaka, Masaru Matsuoka, Akihisa Sutani, et al.
Cureus|March 24, 2020
Gamma Knife Surgery for Residual or Recurrent Craniopharyngioma After Surgical Resection: A Multi-institutional Retrospective Study in JapanTakahiko Tsugawa, Tatsuya Kobayashi, Toshinori Hasegawa, et al.
Pageof 39

Showing results (311-320 of 387) with videos related to

Sort By:
Pageof 39
The Lancet. Oncology|May 4, 2013
CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 studyTakashi Seto, Katsuyuki Kiura, Makoto Nishio, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2015
Factors associated with a poor response to gefitinib in the NEJ002 study: smoking and the L858R mutationTatsuro Fukuhara, Makoto Maemondo, Akira Inoue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Shunichi Sugawara, Koichi Yamazaki, et al.
Clinical Lung Cancer|June 5, 2018
A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study ProtocolYoshihito Kogure, Hideo Saka, Yuichi Takiguchi, et al.
International Surgery|July 25, 2014
Short-term outcomes of simultaneous laparoscopic colectomy and hepatectomy for primary colorectal cancer with synchronous liver metastasesAkira Inoue, Mamoru Uemura, Hirofumi Yamamoto, et al.
Respiratory Investigation|May 24, 2014
Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer: North Japan Lung Cancer Group Trial 0802Yosuke Kawashima, Akira Inoue, Shunichi Sugawara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2015
Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-AnalysisChee Khoon Lee, Yi-Long Wu, Pei Ni Ding, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Randomized phase II study of carboplatin plus irinotecan versus carboplatin plus amrubicin in patients with chemo-naïve extensive-stage small-cell lung cancer: North Japan Lung Cancer Study Group (NJLCG) 0901Naoto Morikawa, Akira Inoue, Shunichi Sugawara, et al.
International Journal of Cancer|July 18, 2009
Frequency of and variables associated with the EGFR mutation and its subtypesTomoaki Tanaka, Masaru Matsuoka, Akihisa Sutani, et al.
Cureus|March 24, 2020
Gamma Knife Surgery for Residual or Recurrent Craniopharyngioma After Surgical Resection: A Multi-institutional Retrospective Study in JapanTakahiko Tsugawa, Tatsuya Kobayashi, Toshinori Hasegawa, et al.
Pageof 39